Day: January 31, 2018

Autismspeaks.org: From skin cells to brain cells for autism research: Part Two

Autismspeaks.org: From skin cells to brain cells for autism research: Part Two

Discoveries made by this Autism Speaks postdoctoral fellow are advancing our understanding of genetic differences in autism – bringing us closer to personalized treatments 

By Autism Speaks Meixner Fellow Aditi Deshpande (class of 2014-16). Dr. Deshpande works under the mentorship of in the Genetics of Autism Research Program in

Read the full article at the original source

Posted by ASD-Search in ASD News, Newsfeed, 0 comments
Managedcaremag.com: FDA Grants Breakthrough Therapy Designation to Balovaptan for Autism

Managedcaremag.com: FDA Grants Breakthrough Therapy Designation to Balovaptan for Autism

The FDA has awarded a breakthrough therapy designation to the investigational oral drug balovaptan (previously known as RG7314, Roche), a vasopressin 1a (V1a) receptor antagonist for individuals with autism spectrum disorder (ASD). Balovaptan has shown the potential to improve social interaction and communication in people with ASD. Evidence from both

Read the full article at the original source

Posted by ASD-Search in ASD News, Newsfeed, 0 comments